Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/2014
12/09/2014US8906968 Process for bacterial stabilizing of aqueous ground natural calcium carbonate and/or precipitated calcium carbonate and/or dolomite and/or surface-reacted calcium carbonate-comprising mineral preparations
12/09/2014US8906950 Ketorolac tromethamine compositions for treating or preventing ocular pain
12/09/2014US8906949 Orally disintegrating tablets of zolmitriptan and process for preparing the same
12/09/2014US8906940 Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
12/09/2014US8906907 Hypotensive lipid and timolol compositions and methods of using same
12/09/2014US8906903 Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker
12/09/2014US8906892 4-pregenen-11β-17-21-triol-3,20-dione derivatives
12/09/2014US8906883 Treatment of oral mucositis by administering an ionic complex of chitosan and a negatively charged polysaccharide selected from heparin, heparan sulfate and dextran sulfate
12/09/2014US8906879 Combination for the treatment of cancer
12/09/2014US8906867 Production method of solid preparation and the solid preparations produced by the method
12/09/2014US8906861 Pharmaceutical compositions comprising cyclosporins
12/09/2014US8906855 Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries
12/09/2014US8906854 Methods for treating metabolic disorders using FGF
12/09/2014US8906851 Method for treating diabetes
12/09/2014US8906687 Blood brain barrier device
12/09/2014US8906686 Method for preparation of implantable constructs
12/09/2014US8906503 Fine particles of crystalline polyol, and method of preparing same
12/09/2014US8906424 Licorice polyphenol preparation
12/09/2014US8906423 Topical phytotherapeutic compound for the treatment of herpes based on Uncaria tomentosa and extraction process for obtaining a vegetal extract from Uncaria tomentosa
12/09/2014US8906421 Methods of dissolving blood clots and the like
12/09/2014US8906420 Pharmaceutical formulation comprising one or more fumaric acid esters in an erosion matrix
12/09/2014US8906419 Pharmaceutical composition containing water soluble drug
12/09/2014US8906417 Nanostructures for drug delivery
12/09/2014US8906415 Calcium phosphate nanowhisker particles, method of making and using the same
12/09/2014US8906414 Methods and compositions for improving bioavailability of epigallocatechin gallate (EGCG)
12/09/2014US8906413 Drug formulations having reduced abuse potential
12/09/2014US8906412 GABA analog prodrug sustained release oral dosage forms
12/09/2014US8906411 Pre-compacted calcium-containing compositions
12/09/2014US8906410 Oral dosage form of 25-hydroxyvitamin D
12/09/2014US8906409 Acoustically sensitive drug delivery particles comprising non-lamellar forming phosphatidylcholine
12/09/2014US8906406 Mucoadhesive dispersible pharmaceutical preparation for active-agent dosing in veterinary and human medicine
12/09/2014US8906397 Permeation enhancers for topical formulations
12/09/2014US8906396 High-loading, controlled-release magnesium oral dosage forms and methods for making and using same
12/09/2014US8906395 Pharmaceutical composition in which solubility of partially soluble tricyclic derivative is improved
12/09/2014US8906394 Hyaluronic acid based copolymers
12/09/2014US8906393 Biofilm inhibiting composition
12/09/2014US8906392 Nanocluster compositions and methods
12/09/2014US8906391 Thermorod for active drug release and method for manufacturing the same
12/09/2014US8906368 Immunoglobulin preparations having increased stability
12/09/2014US8906282 Micro-structured and nano-structured surfaces on biodegradable polymers
12/09/2014US8906277 Process for manufacturing a resulting pharmaceutical film
12/09/2014US8906000 Injectable controlled release fluid delivery system
12/09/2014US8905999 Method and apparatus for endolymphatic drug delivery
12/09/2014US8905997 Therapeutic particles suitable for parenteral administration and methods of making and using same
12/09/2014US8905979 Method of administration of a pulmonary surfactant
12/09/2014US8905922 Devices, systems and methods for diagnosing and treating sinusitis and other disorders of the ears, nose and/or throat
12/09/2014US8905913 Method and composition for synchronizing time of insemination
12/09/2014US8904664 Dehydration device and methods for drying biological materials
12/05/2014DE202014104573U1 Pharmazeutische Zusammensetzung zur Schmerzbehandlung A pharmaceutical composition for the treatment of pain
12/05/2014DE202012013134U1 Pharmazeutische Aerosolformulierung von Protease-Inhibitoren und deren Zubereitung A pharmaceutical aerosol formulation of protease inhibitors and their preparation
12/04/2014US20140358094 Composition, the nano-emulsion and transdermal patch, methods of preparation and use thereof for treating traumatic injuries
12/04/2014US20140358092 Method For Administration Of A Probiotic
12/04/2014US20140357731 Healing cream
12/04/2014US20140357708 Oral dosage form of tetrahydrocannabinol and a method of avoiding and/or suppressing hepatic first pass metabolism via targeted chylomicron/lipoprotein delivery
12/04/2014US20140357688 Method for inhibiting ezh2 expression in breast cancer cells
12/04/2014US20140357657 Pharmaceutical Formulation Containing Gelling Agent
12/04/2014US20140357603 Methods for Controlled Release Oral Dosage of a Vitamin D Compound
12/04/2014US20140357586 Solid Carriers for Improved Delivery of Active Ingredients in Pharmaceutical Compositions
12/04/2014US20140356465 Method of treatment using a therapeutic agent for intranasal administration
12/04/2014US20140356460 Use of hypertonic saline to draw fluid out of swollen tissue and relieve nasal congestion
12/04/2014US20140356449 Sore throat remedy
12/04/2014US20140356445 Artificial Cell Constructs For Cellular Manipulation
12/04/2014US20140356444 Drug Loaded Polymeric Nanoparticles and Methods of Making and Using Same
12/04/2014US20140356443 Pharmaceutical composition comprising stable, amorphous, hybrid nanoparticles of at least one protein kinase inhibitor and at least one polymeric stabilizing and matrix-forming component
12/04/2014US20140356442 Pharmaceutical compositions of triptorelin microspheres
12/04/2014US20140356441 Core-shell type particles and method for producing the same
12/04/2014US20140356440 Enteric Coated Multiparticulate Controlled Release Peppermint Oil Composition and Related Methods
12/04/2014US20140356439 Lipidated glycoprotein particles and methods of use
12/04/2014US20140356438 Peripherally administered viscous formulations
12/04/2014US20140356437 Corticosteroids for the Treatment of Joint Pain
12/04/2014US20140356435 Hydrophobic Drug-Delivery Material, Method For Manufacturing Thereof And Methods For Delivery Of A Drug-Delivery Composition
12/04/2014US20140356434 Pharmaceutical formulation
12/04/2014US20140356431 Oral administrable pharmaceutical composition
12/04/2014US20140356430 Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino [2,3-b]pyrazin-2(1h)-one, a solid form thereof and methods of their use
12/04/2014US20140356429 Tablet containing ferric citrate
12/04/2014US20140356428 Tamper resistant dosage form with bimodal release profile
12/04/2014US20140356427 Orally disintegrating tablet containing hydroxyalkyl cellulose microparticles
12/04/2014US20140356426 Tamper-resistant dosage form containing one or more particles
12/04/2014US20140356425 Composition and method for treating neurological disease
12/04/2014US20140356424 Composition for treatment or reduction of symptoms related to premenstrual syndrome (pms), premenstrual disphoric disorder (pmdd), premenopause, menopause or female hormonal disorders, in a pharmaceutical composition containing said form, and process for producing said pharmaceutical form and use of said composition
12/04/2014US20140356423 Formulations of lycopene in combination with bisphosphonates bone resorption inhibitors
12/04/2014US20140356422 Stable pharmaceutical formulation for oral administration comprising levocetirizine or a pharmaceutically acceptable salt thereof, and montelukast or a pharmaceutically acceptable salt thereof
12/04/2014US20140356421 Antibody-Conjugated Double-Emulsion Nanocapsule and Preparation Methods Thereof
12/04/2014US20140356420 Micro-particle comprising a protein extract from sweet potato for extending satiety and controlling blood glucose and lipid levels
12/04/2014US20140356417 Modified drugs for use in liposomal nanoparticles
12/04/2014US20140356416 Liposomal drug encapsulation
12/04/2014US20140356415 Compositions and vaccines comprising vesicles and methods of using the same
12/04/2014US20140356414 Targeted Crosslinked Multilamellar Liposomes
12/04/2014US20140356413 Retinoid-liposomes for treating fibrosis
12/04/2014US20140356412 Non-Aqueous Patch
12/04/2014US20140356411 Plasmonic-magnetic bifunctional nanotubes for biological applications
12/04/2014US20140356378 BMP-1 Procollagen C-Proteinase for Diagnosis and Treatment of Bone and Soft Tissue Defects and Disorders
12/04/2014US20140356297 Oral compositions for absorption of phosphorous compounds
12/04/2014US20140356294 Dosage that is safeguarded from abuse
12/04/2014US20140356289 Multisomes: Encapsulated Droplet Networks
12/04/2014US20140356288 Topical Examination Compositions and Methods
12/04/2014US20140356271 Methods and materials for making cerium nanoparticles
12/03/2014DE212014000004U1 Abgabesystem für Sägepalmextrakt und Carotinoid Delivery system for saw palmetto extract and carotenoid
12/02/2014US8901303 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
12/02/2014US8901167 Product and process for inhibition of biofilm development
1 ... 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 ... 2991